For example, it will be interesting to analyze the CTLs that infiltrate myeloid sarcomas, which are sometimes observed in advanced MLL/AF9 leukemia, and compare them with those in BM or spleen. This evidence concerns the gene KMT2A and myeloid sarcoma.